This study investigated the effects of nicotine, the chemical responsible f
or tobacco addiction, on bone and on serum mineral and calcitropic hormone
levels in adult, female rats to help resolve a current controversy regardin
g the impact of nicotine on bone health, Seven-month-old rats received eith
er saline (n = 12), Iow-dose nicotine (4.5 mg/kg/day, n = 2), or high-dose
nicotine (6.0 mg/kg/day, n = 12) administered subcutaneously via osmotic mi
nipumps for 3 months. Blood, femora, tibiae, and lumbar vertebrae (3-5) wer
e collected at necropsy for determination of serum mineral and hormonal con
centrations, bone density (femora and vertebrae), bone turnover (tibiae), a
nd bone strength (femora). The presence of nicotine in serum (111 +/- 7 and
137 +/- 10 ng/ml for the low- and high-dose nicotine groups, respectively)
confirmed successful delivery of the drug via osmotic minipumps. Nicotine-
induced treatment differences were not detected in serum calcium, 25-hydrox
yvitamin D, and 1,25-dihydroxyvitamin D. However, serum phosphorus and para
thyroid hormone (PTH) were higher in rats treated with high-dose nicotine,
and serum calcitonin was lower in rats treated with both high- and low-dose
nicotine than in control rats. Nicotine treatment had no effect on tibial
cancellous or cortical bone turnover or femoral bone mineral content (BMC)
and density (BMD). Femoral ultimate load and vertebral BMC were lower in ra
ts treated with high-dose, nicotine than in control rats. We conclude that
nicotine at serum concentrations 2.5-fold greater than the average in smoke
rs has limited detrimental effects on bone in normal, healthy female rats.